DK0706401T3 - Lægemiddelafgivelsessystem - Google Patents

Lægemiddelafgivelsessystem

Info

Publication number
DK0706401T3
DK0706401T3 DK94918945T DK94918945T DK0706401T3 DK 0706401 T3 DK0706401 T3 DK 0706401T3 DK 94918945 T DK94918945 T DK 94918945T DK 94918945 T DK94918945 T DK 94918945T DK 0706401 T3 DK0706401 T3 DK 0706401T3
Authority
DK
Denmark
Prior art keywords
matrix
drug
delivery system
drug delivery
receptor
Prior art date
Application number
DK94918945T
Other languages
Danish (da)
English (en)
Inventor
Margaret Joan Taylor
Original Assignee
Univ Montfort
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montfort filed Critical Univ Montfort
Application granted granted Critical
Publication of DK0706401T3 publication Critical patent/DK0706401T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94918945T 1993-06-30 1994-06-27 Lægemiddelafgivelsessystem DK0706401T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313484A GB9313484D0 (en) 1993-06-30 1993-06-30 Drug system ii
PCT/GB1994/001384 WO1995001186A1 (en) 1993-06-30 1994-06-27 Drug system

Publications (1)

Publication Number Publication Date
DK0706401T3 true DK0706401T3 (da) 2003-03-03

Family

ID=10738039

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94918945T DK0706401T3 (da) 1993-06-30 1994-06-27 Lægemiddelafgivelsessystem

Country Status (11)

Country Link
US (2) US5902607A (de)
EP (1) EP0706401B1 (de)
JP (1) JP4572008B2 (de)
AT (1) ATE228374T1 (de)
AU (1) AU7004194A (de)
DE (1) DE69431800T2 (de)
DK (1) DK0706401T3 (de)
ES (1) ES2185654T3 (de)
GB (1) GB9313484D0 (de)
PT (1) PT706401E (de)
WO (1) WO1995001186A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system
GB0116860D0 (en) * 2001-07-10 2001-09-05 Univ Montfort Gel compositions
CA2509382A1 (en) 2002-12-17 2004-07-08 Todd C. Zion Stimuli-responsive systems for controlled drug delivery
GB0412631D0 (en) * 2004-06-07 2004-07-07 Cambridge Applied Polymers Ltd Polymer release system
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
US7687608B2 (en) 2005-10-19 2010-03-30 Smartcells, Inc. Methods for reducing the mitogenicity of lectin compositions
EP2117601A2 (de) * 2006-12-22 2009-11-18 The Regents of the University of California Makromolekulare konjugate von zystische-fibrose-transmembran-leitwert-regulatorprotein-inhibitoren und verwendungen davon
WO2010088276A2 (en) * 2009-01-28 2010-08-05 Smartcells, Inc. Polynucleotide aptamer-based cross -linked materials and uses thereof
BRPI1007457A2 (pt) 2009-01-28 2015-08-25 Smartcells Inc Conjungado, formulação de liberação prolongada, e, sistema de distribuição de bomba.
WO2010088268A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Exogenously triggered controlled release materials and uses thereof
WO2010088286A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Synthetic conjugates and uses thereof
WO2010088300A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Crystalline insulin-conjugates
US9095623B2 (en) * 2009-03-20 2015-08-04 Smartcells, Inc. Terminally-functionalized conjugates and uses thereof
US8623345B2 (en) 2009-03-20 2014-01-07 Smartcells Terminally-functionalized conjugates and uses thereof
WO2010107520A1 (en) 2009-03-20 2010-09-23 Smartcells, Inc. Soluble non-depot insulin conjugates and uses thereof
EP2598522A4 (de) 2010-07-28 2014-11-12 Smartcells Inc Rekombinante lektine, bindungsstellenmodifizierte lektine und anwendungen davon
AU2011282977A1 (en) 2010-07-28 2013-02-21 Smartcells, Inc. Drug-ligand conjugates, synthesis thereof, and intermediates thereto
JP2013535467A (ja) 2010-07-28 2013-09-12 スマートセルズ・インコーポレイテツド 組換えにより発現されたインスリンポリペプチドおよびその使用
US9994615B2 (en) * 2012-02-17 2018-06-12 Massachusetts Institute Of Technology Self-regulated peptide hydrogel for insulin delivery
GB201310185D0 (en) 2013-06-07 2013-07-24 Univ Montfort Container
GB201314640D0 (en) 2013-08-15 2013-10-02 Univ Montfort Matrix gel
KR20160065930A (ko) 2013-10-04 2016-06-09 머크 샤프 앤드 돔 코포레이션 글루코스-반응성 인슐린 접합체
WO2018175272A1 (en) 2017-03-23 2018-09-27 Merck Sharp & Dohme Corp. Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes
US11413352B2 (en) 2017-12-18 2022-08-16 Merck, Sharp & Dohme LLC Conjugate based systems for controlled insulin delivery
EP3727424A4 (de) 2017-12-18 2021-10-27 Merck Sharp & Dohme Corp. Konjugatbasierte systeme für kontrollierte insulinfreisetzung
CN108721605B (zh) * 2018-06-01 2022-10-14 华南师范大学 一种装载有胰岛素的纳米粒子及其应用
EP4072590A4 (de) * 2019-12-13 2024-01-03 Folium Labs Inc. Ein kohlenhydratpolymer und einen wirkstoff enthaltende komplexe und verfahren zu ihrer herstellung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348387A (en) * 1979-07-31 1982-09-07 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
HK1002252A1 (en) * 1991-04-02 1998-08-07 Biotech Australia Pty. Limited Oral delivery systems for microparticles
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system

Also Published As

Publication number Publication date
US6410053B1 (en) 2002-06-25
WO1995001186A1 (en) 1995-01-12
ES2185654T3 (es) 2003-05-01
DE69431800D1 (de) 2003-01-09
ATE228374T1 (de) 2002-12-15
AU7004194A (en) 1995-01-24
JP4572008B2 (ja) 2010-10-27
US5902607A (en) 1999-05-11
EP0706401B1 (de) 2002-11-27
JPH09501416A (ja) 1997-02-10
DE69431800T2 (de) 2003-09-04
GB9313484D0 (en) 1993-08-11
PT706401E (pt) 2003-03-31
EP0706401A1 (de) 1996-04-17

Similar Documents

Publication Publication Date Title
DK0706401T3 (da) Lægemiddelafgivelsessystem
ATE122879T1 (de) Verabreichungsformen für pharmaka.
US5656284A (en) Oral transmucosal delivery tablet and method of making it
WO2003077972A3 (en) Implantable drug delivery system
CS9004859A2 (en) Method of adhesive plaster production that contains oestrogen as active substance
BR9608542A (pt) Composição para a liberação sustentada de hormónio do crescimento humano
ATE178485T1 (de) Transdermales arzneistoff-abgabesystem
DE69212497D1 (de) Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe
ATE516049T1 (de) Formulierung zur gesteuerten arzneistofffreisetzung durch kombination hydrophiler und hydrophober stoffe
ATE59302T1 (de) Klebende schicht zur transdermalen freigabe.
UA35569C2 (uk) Композиція для пролонгованого і контрольованого вивільнення пептидної лікарської речовини і спосіб її одержання, спосіб приготування суспензії, що призначена для парентерального введення
AU7465087A (en) Controlled release bioerodible drug delivery system
PL339861A1 (en) System for delivering a drug of retarded total release within the region of gastrointestinal tract
ATE143257T1 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
ATE188866T1 (de) Transdermales arzneimittelverabreichungssystem
ES2135458T3 (es) Sistema de medicamento que comprende una matriz de gel que contiene un farmaco inmobilizado.
IT1243745B (it) Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
EP0873751A3 (de) Pharmazeutisches produkt zur anwendung auf der mukosa der gebärmutter
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
Hartmann Mania or hypomania after withdrawal from antidepressants.